ALPMY vs. DCTH

Last updated Apr 1, 2026

Compare and contrast key facts about Astellas Pharma Inc (ALPMY) and Delcath Systems, Inc. (DCTH).

Performance

ALPMY vs. DCTH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Astellas Pharma Inc (ALPMY) and Delcath Systems, Inc. (DCTH). The values are adjusted to include any dividend payments, if applicable.

ALPMY vs. DCTH - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
ALPMY Astellas Pharma Inc	22.05%	41.23%	-17.10%	-21.50%	-6.82%	5.38%	-9.34%	35.81%	-18.25%
DCTH Delcath Systems, Inc.	-8.12%	-16.11%	189.42%	15.56%	-53.55%	-56.75%	-15.67%	-89.16%	-90.66%

Fundamentals

Market Cap ALPMY : $29.15B DCTH : $338.22M
EPS ALPMY : $181.46 DCTH : $0.07
PE Ratio ALPMY : 0.09 DCTH : 133.78
PS Ratio ALPMY : 0.01 DCTH : 5.60
PB Ratio ALPMY : 0.02 DCTH : 3.04
Total Revenue (TTM) ALPMY : $2.08T DCTH : $64.50M
Gross Profit (TTM) ALPMY : $1.62T DCTH : $73.43M
EBITDA (TTM) ALPMY : $599.42B DCTH : $1.61M

Returns By Period

In the year-to-date period, ALPMY achieves a 22.05% return, which is significantly higher than DCTH's -8.12% return.

ALPMY

• 1D: 0.50%
• 1M: -1.76%
• YTD: 22.05%
• 6M: 49.08%
• 1Y: 67.91%
• 3Y*: 6.21%
• 5Y*: 1.96%
• 10Y*: 3.20%

DCTH

• 1D: 4.39%
• 1M: 4.27%
• YTD: -8.12%
• 6M: -13.67%
• 1Y: -27.10%
• 3Y*: 17.30%
• 5Y*: -5.40%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ALPMY vs. DCTH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALPMY

ALPMY Risk / Return Rank: 93
ALPMY Sharpe Ratio Rank: 94
ALPMY Sortino Ratio Rank: 93
ALPMY Omega Ratio Rank: 91
ALPMY Calmar Ratio Rank: 94
ALPMY Martin Ratio Rank: 93

DCTH

DCTH Risk / Return Rank: 24
DCTH Sharpe Ratio Rank: 21
DCTH Sortino Ratio Rank: 21
DCTH Omega Ratio Rank: 23
DCTH Calmar Ratio Rank: 24
DCTH Martin Ratio Rank: 29

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ALPMY vs. DCTH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Astellas Pharma Inc (ALPMY) and Delcath Systems, Inc. (DCTH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ALPMY	DCTH	Difference
Sharpe ratio Return per unit of total volatility	2.47	-0.47	+2.94
Sortino ratio Return per unit of downside risk	3.26	-0.39	+3.65
Omega ratio Gain probability vs. loss probability	1.41	0.95	+0.45
Calmar ratio Return relative to maximum drawdown	5.54	-0.54	+6.08
Martin ratio Return relative to average drawdown	13.50	-0.77	+14.27
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ALPMY vs. DCTH - Sharpe Ratio Comparison

The current ALPMY Sharpe Ratio is 2.47, which is higher than the DCTH Sharpe Ratio of -0.47. The chart below compares the historical Sharpe Ratios of ALPMY and DCTH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ALPMY	DCTH	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.47	-0.47	+2.94
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.08	-0.07	+0.15
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.13	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.14	-0.45	+0.31

Correlation

The correlation between ALPMY and DCTH is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ALPMY vs. DCTH - Dividend Comparison

Neither ALPMY nor DCTH has paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
ALPMY Astellas Pharma Inc	0.00%	1.93%	2.56%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.20%	2.18%
DCTH Delcath Systems, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

ALPMY vs. DCTH - Drawdown Comparison

The maximum ALPMY drawdown since its inception was -83.67%, smaller than the maximum DCTH drawdown of -99.96%. Use the drawdown chart below to compare losses from any high point for ALPMY and DCTH.

Drawdown Indicators

	ALPMY	DCTH	Difference
Max Drawdown Largest peak-to-trough decline	-83.67%	-99.96%	+16.29%
Max Drawdown (1Y) Largest decline over 1 year	-12.21%	-54.75%	+42.54%
Max Drawdown (5Y) Largest decline over 5 years	-49.11%	-85.10%	+35.99%
Max Drawdown (10Y) Largest decline over 10 years	-49.67%	—	—
Current Drawdown Current decline from peak	-70.04%	-99.85%	+29.81%
Average Drawdown Average peak-to-trough decline	-58.27%	-96.38%	+38.11%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.01%	38.26%	-33.25%

Volatility

ALPMY vs. DCTH - Volatility Comparison

The current volatility for Astellas Pharma Inc (ALPMY) is 9.35%, while Delcath Systems, Inc. (DCTH) has a volatility of 12.83%. This indicates that ALPMY experiences smaller price fluctuations and is considered to be less risky than DCTH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ALPMY	DCTH	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.35%	12.83%	-3.48%
Volatility (6M) Calculated over the trailing 6-month period	21.45%	36.46%	-15.01%
Volatility (1Y) Calculated over the trailing 1-year period	27.59%	58.48%	-30.89%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	25.16%	74.15%	-48.99%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.44%	111.20%	-85.76%

Financials